Literature DB >> 16165347

Squamous cell carcinoma of the anal canal.

Dennis L Rousseau1, Charles R Thomas, Nicholas J Petrelli, Morton S Kahlenberg.   

Abstract

Squamous cell carcinoma (SCC) of the anal canal is a rare condition with increasing incidence rates in the United States population in the past several decades. This review article provides a complete overview of the etiology, anatomy and the approach to the multidisciplinary management of the patient with anal SCC. Chemoradiation therapy for the treatment of SCC of the anal canal provides excellent disease control and survival while preserving anal sphincter function in the majority of patients. The surgeon plays a key role in the diagnosis and follow-up of this disease. Surgical salvage with APR for disease persistence or recurrence in carefully selected patients can result in reasonable 5-year survivals.

Entities:  

Mesh:

Year:  2005        PMID: 16165347     DOI: 10.1016/j.suronc.2005.07.002

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  10 in total

1.  Current therapeutic strategies for anal squamous cell carcinoma in Japan.

Authors:  Atsuo Takashima; Yasuhiro Shimada; Tetsuya Hamaguchi; Yoshinori Ito; Tadahiko Masaki; Shigeki Yamaguchi; Yukifumi Kondo; Norio Saito; Tomoyuki Kato; Masayuki Ohue; Masayuki Higashino; Yoshihiro Moriya
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

2.  Radiochemotherapy in Anal Cancer: cCR, clinical outcomes and quality of life using two different treatment schedules.

Authors:  Sara Di Santo; Marianna Trignani; Matteo Neri; Angelo Milano; Paolo Innocenti; Maria Taraborrelli; Antonietta Augurio; Annamaria Vinciguerra; Monica Di Tommaso; Lucia Anna Ursini; Angelo Di Pilla; Marta Di Nicola; Domenico Genovesi
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-22

3.  Anal dysplasia screening: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2007-06-01

4.  Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Authors:  Izumi Tachibana; Yasumasa Nishimura; Masahiro Inada; Kohei Fukuda; Kazuki Ishikawa; Tatsuyuki Nishikawa; Masaki Yokokawa; Kiyoshi Nakamatsu; Shuichi Kanamori; Jin-Ichi Hida
Journal:  Int J Clin Oncol       Date:  2018-07-10       Impact factor: 3.402

Review 5.  Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.

Authors:  T Lampejo; D Kavanagh; J Clark; R Goldin; M Osborn; P Ziprin; S Cleator
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

6.  Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis.

Authors:  Alessandra Arcelli; Milly Buwenge; Gabriella Macchia; Silvia Cammelli; Francesco Deodato; Savino Cilla; Andrea Galuppi; Valeria Panni; Gian Carlo Mattiucci; Luca Tagliaferri; Alessio G Morganti
Journal:  J Contemp Brachytherapy       Date:  2019-02-28

Review 7.  Ten-Year experience with vertical rectus abdominis myocutaneous flap for reconstruction of abdominoperineal resection defects.

Authors:  Gabrielle A LaBove; Gregory Rd Evans; Brian Biggerstaff; Brandon K Richland; Seung Ah Lee; Derek A Banyard; Nima Khoshab
Journal:  JPRAS Open       Date:  2020-11-30

8.  Long term outcome after combined modality treatment for anal cancer.

Authors:  Irena Oblak; Primoz Petric; Franc Anderluh; Vaneja Velenik; Peter Albert Fras
Journal:  Radiol Oncol       Date:  2012-04-11       Impact factor: 2.991

9.  Development of cerebral metastasis after medical and surgical treatment of anal squamous cell carcinoma.

Authors:  Andrew Austin Gassman; Emil Fernando; Casey Jacob Holmes; Umesh Kapur; Joshua M Eberhardt
Journal:  Case Rep Oncol Med       Date:  2012-10-09

10.  Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations.

Authors:  Christopher Mathews; Joseph Caperna; Edward R Cachay; Bard Cosman
Journal:  Open AIDS J       Date:  2007-11-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.